see teva s sites around the world americas canada curacao united states growth markets argentina australia belarus brazil chile china india israel kazakhstan mexico peru russia singapore south africa turkey ukraine uruguay uzbekistan japan & s. korea japan south korea europe europe austria belgium bosnia & herzegovina bulgaria croatia czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania macedonia monaco netherlands norway poland portugal romania serbia slovakia slovenia spain sweden switzerland united kingdom see all see less want to find out more about teva s locations and phone numbers visit teva worldwide teva acquiresactavis generics teva acquiresactavis generics read more we have taken great steps towards changing teva profoundly in a way that further highlights what makes us unique in this industry erez vigodman president and chief executive officer discover more we are creating breakthroughs in neurodegeneration . teva s national network of excellence will contribute to the quality of life of us all . dr. daniel offen tel aviv university discover more copaxone and azilect came from israeli universities . why wouldn t we tap into this incredible expertise and innovation of israeli universities to find the next jewels . dr. michael hayden president of global r & d andchief scientific officer teva discover more i hope the challenge i overcome by doing the ride serves as an inspiration to those that have ms. matt ferko athlete and ms patient discover more our single minded focus through the skills of our scientists is to ensure that we bring essential generic medicines of high quality to the greatest number of in the fastest time possible . elizabeth kogan svp global generics r & d teva discover more today we can understand the processes resultingin disease and response to drugs in individual patients with greater precision than ever before . dr. iris grossman global head personalized medicineand pharmacogenomics teva discover more our nte process reflects our expertise ingenerics and specialty drugs and the synergiescreated when these capabilities are integrated . dr. michael hayden president of global r & d andchief scientific officer teva discover more our collaboration with teva will contribute greatly to the korean pharmaceutical industry by supplying innovative medicines at affordable prices . young jin kim ceo & chairman handok discover more in china there is an increasing demand forquality generic medication . we were very impressedby teva s oncology cns and respiratory portfolio . yin li deputy minister and head of thechinese food and drug administration cfda discover more there is no greater pleasure than in sharingour knowledge with younger generations . arinachaushu teva global r & d discover more our dna is the combination of p & g and teva . our mission is to understand what people wantand need and then find innovative ways to deliver that . briain de buitlier ceo pgt healthcare discover more we are excited to develop environmentally friendly technologies to create a healthier world for our customers worldwide . prof. ernest mestrovic tapi r & d senior director croatia discover more about about lobby company profile corporate officers corporate governance board of directors excellence our history actavis integration 2015 annual report on form 20 f quality products products lobby specialty generic products generic faq over the counter otc api quality central nervous system cns respiratory research research lobby integrated r & d our focus patient promise pipeline business development teva at iati biomed 2015 leading the fight for cures exceptional people national network of excellence responsibility responsibility lobby improving outcomes meeting needs joining forces beyond prescriptions healthy futures our communities teva awards responsibility highlights 2014 full report previous csr reports global patient organization and advocacy disclosure 2015 media media lobby latest news featured stories media albums teva fact sheet teva overview inspiring change for women in japan pliva awarded two golden keys climbing against ms investors investors lobby news webcasts and presentations corporate governance financial information stock information shareholder information teva in focus analysts coverage consensus investor kit contact us careers careers lobby our people grow with the best our guiding values leadership development european leadership programme our people grow with the best teva worldwide stock contact us hebrew follow us teva in action see what we re doing and where all news top news oct 12 2016 teva announces launch of generic beyaz in the united states learn more share top news oct 6 2016 teva and celltrion announce exclusive biosimilar commercial partnership learn more share top news oct 5 2016 teva announces sale of uk and ireland actavis assets and operations learn more share top news oct 3 2016 teva completes acquisition of anda inc. learn more share top news sep 29 2016 teva announces launch of generic epzicom tablets in the united states learn more share guy hadari it leads teva s technology revolution discover more featured stories take a closer look at what s happening at teva all featured stories teva responds to the zika virus public health emergency discover more tapi launches upgraded customer portal tapi has launched its upgraded customer portal tapi online . this exciting new portal provides full support for api projects including a range of tools and a comprehensive api document library . discover more teva celebrates full compliance discover more dr. gonen in pharmatimes discover more new plant in croatia croatian prime minister tihomir ore kovi opens teva s new multi purpose synthesis plant in savski marof . discover more how our uniqueness creates healthcare confidence around the world people know that our ultimate goal is their health and well being . find out how we do it specialized in cns & respiratory cutting edge r & d uncompromising quality the world s generic leader corporate responsibility about company profile corporate officers corporate governance board of directors excellence our history actavis integration products specialty generic products generic faq over the counter otc api quality research integrated r & d our focus patient promise pipeline business development teva at iati biomed 2015 responsibility improving outcomes meeting needs joining forces beyond prescriptions healthy futures our communities teva awards responsibility highlights 2014 full report media latest news featured stories media albums teva fact sheet teva overview investors news webcasts and presentations corporate governance financial information stock information shareholder information teva in focus analysts coverage consensus investor kit contact us careers our people grow with the best our guiding values leadership development european leadership programme follow teva legal notes data privacy tapi sitemap 2015 teva pharmaceutical industries ltd. .